SPIRIT 2013 clinical trial protocol guidelines issued

January 10, 2013
SPIRIT 2013 clinical trial protocol guidelines issued
A panel of experts, including trial investigators, trial coordinators, and representatives from ethics and regulatory agencies, has developed the Standard Protocol Items: Recommendations for Interventional Trials 2013 guidelines for the minimum content of a clinical trial, according to a statement published online Jan. 8 in the Annals of Internal Medicine.

(HealthDay)—A panel of experts, including trial investigators, trial coordinators, and representatives from ethics and regulatory agencies, has developed the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 guidelines for the minimum content of a clinical trial, according to a statement published online Jan. 8 in the Annals of Internal Medicine.

Noting that existing guidelines for protocols vary in their scope and recommendation, seldom describe development, and rarely cite stakeholder involvement or evidence to support their recommendations, An-Wen Chan, M.D., D.Phil., of the University of Toronto, and colleagues developed a 33-item SPIRIT checklist to serve as a guideline for the minimum content of a clinical trial protocol. The authors collaborated with 115 key stakeholders, including trial investigators; ; and representatives from research ethics, industry, and regulatory agencies.

The authors report that the checklist applies to protocols for all clinical trials, with a focus on content, and recommends a full description of the planned trial. The SPIRIT recommendations aim to facilitate drafting of protocols by offering a standard for content. The transparency and completeness of trial protocols would be enhanced by adherence to SPIRIT, benefiting investigators, trial participants, funders, ethics committees, and other relevant parties.

"An extensive range of stakeholders could benefit from widespread use of the SPIRIT 2013 statement and its explanatory paper. Pilot-testing and informal feedback have shown that it is particularly valuable for trial investigators when they draft their protocols," the authors write. "It can also serve as a for new investigators, peer reviewers, and research ethics committee or institutional review board members."

Several authors disclosed to the pharmaceutical industry.

Explore further: Clinical study of epilepsy drug may have been purely promotional

More information: Abstract
Full Text

Related Stories

Clinical study of epilepsy drug may have been purely promotional

June 27, 2011
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according ...

More information on trial site investigators needed

December 27, 2011
Despite the importance of site investigators to the success of multicentre clinical trials, inadequate public information is available about their recruitment performance.

New migraine clinical trial guidelines

January 24, 2012
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available ...

New study confirms the existence of 'trial effect' in HIV clinical trials

July 13, 2011
A new study by investigators from the University of North Carolina at Chapel Hill School of Medicine has confirmed the existence of a "trial effect" in clinical trials for treatment of HIV.

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.